Articles published in Cancer Science & Therapy have been cited by esteemed scholars and scientists all around the world.
Cancer Science & Therapy has got h-index 27, which means every article in Cancer Science & Therapy has got 27 average citations.
Following are the list of articles that have cited the articles published in Cancer Science & Therapy.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|---|---|
Total published articles |
57 | 46 | 70 | 59 | 42 | 78 | 71 |
Research, Review articles and Editorials |
3 | 4 | 18 | 22 | 27 | 26 | 69 |
Research communications, Review communications, Editorial communications, Case reports and Commentary |
41 | 45 | 52 | 37 | 15 | 52 | 2 |
Conference proceedings |
0 | 21 | 45 | 12 | 0 | 162 | 404 |
Citations received as per Google Scholar, other indexing platforms and portals |
4129 | 3358 | 294 | 348 | 345 | 373 | 344 |
Journal total citations count | 5332 |
Journal impact factor | 2.06 |
Journal 5 years impact factor | 2.85 |
Journal cite score | 6.17 |
Journal h-index | 27 |
Journal h-index since 2019 | 18 |
Lorenzo VP, Mendonça Júnior FJ, Scotti L, Scotti MT (2016) Theoretical Study of Phosphoethanolamine: A Synthetic Anticancer Agent with Broad Antitumor Activity. Journal of Chemistry. |
|
Saxena R, Yang C, Rao M, Turaga RC, Garlapati C, at al. (2017) Preclinical development of a non-toxic oral formulation of monoethanolamine, a lipid precursor, for prostate cancer treatment. Clinical Cancer Research, clincanres-1716. |
|
Naga Anusha P, Siddiqui A, Hima Bindu A (2011) Immuno Defense Mechanism against Tumors. J Cancer Sci Ther S 17: 2. |
|
Arun Kumar R, Sathish Kumar D, Nishanth T (2011) A Review on Stem cell Research & Their Role in Various Diseases. J Stem Cell Res Ther 1(3: 1-5. |
|
Karanova MV (2013) Influence of Low Temperature on the Evolution of Amino Acid Pools Adaptive Modifications inPoikilothermal Animals. International Journal of Biochemistry and Biophysics 1(2): 33-40. |
|
Siddiqui A, Jeevani T, Naga Anusha P, Hima Bindu A (2011) Stem cell therapy for liver diseases. J Stem Cell Res Ther 1(111): 2. |
|
Azevedo RA, Ferreira AK, Auada AV, Pasqualoto KF, et al. (2012) Antitumor effect of cationic INKKI peptide from bovine β-casein on melanoma B16F10. |
|
Ferreira AK, Meneguelo R, Marques FL, Radin A, R Filho OM, et al. (2012) phosphoethanolamine a precursor of membrane phospholipids reduce tumor growth in mice bearing melanoma B16-F10 and in vitro induce apoptosis and arrest in G2/M phase. Biomedicine & Pharmacotherapy 66(7): 541-548. |
|
Ferreira AK, Freitas VM, Levy D, Ruiz JL, Bydlowski SP (2013) Anti-angiogenic and anti-metastatic activity of synthetic phosphoethanolamine. PLoS One 8(3): e57937. |
|
Ferreira AK, Freitas VM, Levy D, Ruiz JL, Bydlowski SP (2013 Anti-angiogenic and anti-metastatic activity of synthetic phosphoethanolamine. PLoS One 8(3): e57937. |
|
Engel N, Lisec J, Piechulla B, Nebe B (2012 Metabolic profiling reveals sphingosine-1-phosphate kinase 2 and lyase as key targets of (phyto-) estrogen action in the breast cancer cell line MCF-7 and not in MCF-12A. PLoS One 7(10: e47833. |
|
Tata A, Fernandes AM, Santos VG, Alberici RM, Araldi D (2012) Nanoassisted laser desorption-ionization-MS imaging of tumors. Analytical chemistry 84(15):6341-6345. |
|
Ferreira AK, Meneguelo R, Pereira A, R FILHO OM, Chierice GO (2012) Anticancer effects of synthetic phosphoethanolamine on Ehrlich ascites tumor: an experimental study. Anticancer research 32(1):95-104. |
|
Pabst TM, Wendeler M, Wang X, Bezemer S, Hermans P, et al. (2017 affinity ligands enable separation of closely related biopharmaceuticals. Biotechnology Journal 12: 2 |
|
Naga Anusha P, Siddiqui A, Hima Bindu A (2011) Immuno Defense Mechanism against Tumors. J Cancer Sci Ther S.17: 2. |
|
Linke T, Aspelund MT, Thompson C, Xi G, Fulton A (2014) Development and scaleâ€Âup of a commercial fed batch refolding process for an antiâ€ÂCD22 two chain immunotoxin. Biotechnology progress 30(6): 1380-1389. |
|
Linke T, Feng J, Yu K, Kim HJ, Wei Z et al. (2012) Process scale separation of an anti-CD22 immunotoxin charge variant. Journal of Chromatography A 1260: 120-125. |
|
Burden RE, Caswell J, Fay F, Scott CJ (2012) Recent advances in the application of antibodies as therapeutics. Future medicinal chemistry 1:73-86. |
|
Madhumathi J, Devilakshmi S, Sridevi S, Verma RS (2016) Immunotoxin therapy for hematologic malignancies: where are we heading?. Drug discovery today 21: 325-332. |
|
Kawa S, Onda M, Ho M, Kreitman RJ, Bera TK, et al. (2011) The improvement of an anti-CD22 immunotoxin: conversion to single-chain and disulfide stabilized form and affinity maturation by alanine scan. InMAbs 3: 479-486. |
|
Cancer Science & Therapy received 5332 citations as per Google Scholar report